Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TMBquant: an explainable AI-powered caller advancing tumor mutation burden quantification across heterogeneous samples. | Brief Bioinform | 2025 | 40919911 | PubTator, text mining | PubMed |
| Lifespan Tree of Brain Anatomy: Diagnostic Values for Motor and Cognitive Neurodegenerative Diseases. | Hum Brain Mapp | 2025 | 40888533 | PubTator, text mining | PubMed |
| Pathogenic variants in MAEA disrupt DNA replication fork stability and are associated with developmental abnormalities in humans. | Sci Adv | 2025 | 40880485 | PubTator, text mining | PubMed |
| ESM2_AMP: an interpretable framework for protein-protein interactions prediction and biological mechanism discovery. | Brief Bioinform | 2025 | 40874821 | PubTator, text mining | PubMed |
| Camptothecin, a topoisomerase I inhibitor, impedes productive herpes simplex virus type 1 infection. | J Virol | 2025 | 40874743 | PubTator, text mining | PubMed |
| WMSA-WBS: Efficient Wave Multi-Head Self-Attention with Wavelet Bottleneck. | Sensors (Basel) | 2025 | 40871908 | PubTator, text mining | PubMed |
| Food Image Recognition Based on Anti-Noise Learning and Covariance Feature Enhancement. | Foods | 2025 | 40870689 | PubTator, text mining | PubMed |
| SLFN11, far from being limited to responding to cancer DNA damage. | Clin Exp Med | 2025 | 40856812 | PubTator, text mining | PubMed |
| CF10/LV overcomes acquired resistance to 5-FU/LV in colorectal cancer cells through downregulation of the c-Myc/ABCB5 axis. | Cancer Drug Resist | 2025 | 40843355 | PubTator, text mining | PubMed |
| Discovery of novel SND1 inhibitors by in silico-based molecular docking and dynamics simulation methods for managing hepatocellular carcinoma. | Sci Rep | 2025 | 40841409 | PubTator, text mining | PubMed |
| Compound Kushen Injection suppresses multiple myeloma progression via TOP1-targeted coordination of DNA damage and endoplasmic reticulum stress. | Phytomedicine | 2025 | 40839989 | PubTator, text mining | PubMed |
| Multimodal analysis of cell-free DNA enhances differentiation of early-stage breast cancer from benign lesions and healthy individuals. | BMC Biol | 2025 | 40830871 | PubTator, text mining | PubMed |
| High efficiency classification of thyroid cytopathological images based on knowledge distillation and vision transformer. | Sci Rep | 2025 | 40820155 | PubTator, text mining | PubMed |
| The Kinase Inhibitor GNF-7 Is Synthetically Lethal in Topoisomerase 1-Deficient Ewing Sarcoma. | Cancers (Basel) | 2025 | 40805174 | PubTator, text mining | PubMed |
| AlphaFold 3: an unprecedent opportunity for fundamental research and drug development. | Precis Clin Med | 2025 | 40799364 | PubTator, text mining | PubMed |
| Epigenetic control of topoisomerase 1 activity presents a cancer vulnerability. | Nat Commun | 2025 | 40796804 | PubTator, text mining | PubMed |
| Longitudinal single-cell analysis of glucagon-like peptide-2 treatment in patients with short bowel syndrome. | JCI Insight | 2025 | 40773292 | PubTator, text mining | PubMed |
| Two classes of syncytiotrophoblast nuclei form following BAP-driven human pluripotent stem cell differentiation. | Placenta | 2025 | 40768794 | PubTator, text mining | PubMed |
| SLFN11: a pan-cancer biomarker for DNA-targeted drugs sensitivity and therapeutic strategy guidance. | Front Oncol | 2025 | 40766331 | PubTator, text mining | PubMed |
| Preclinical Pharmacokinetic, Pharmacodynamic, and Safety Profile of OBI-992: A Novel TROP2-Targeted Antibody-Drug Conjugate. | Mol Cancer Ther | 2025 | 40762235 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=10